Managing Cancer Breakthrough Pain is a comprehensive review of cancer
breakthrough pain (cBTP) and rapid-onset opioids (ROO), the only
treatment approved for cBTP episodes. The book was originally
commissioned due to the current rapid growth of the ROO market and the
epidemic of ROO abuse. This book will review the historical background
and definitions of cBTP and ROOs, assessment methods to determine types
of cBTP, US- and EU-approved ROOs, case studies (which will provide
practical applications of ROO treatment options), ROO abuse and
screening methods, and the FDA-mandated TIRF REMS Access program
(Transmucosal Immediate Release Fentanyl Risk Evaluation and Mitigation
Strategies Access program). Busy healthcare professionals who have a
basic understanding of cancer pain but want to learn more about cBTP and
ROOs will benefit from this concise guide that will help them quickly
understand the complexities of cBTP episodes and ROOs.